CRISPR Cas9 Platform Provides One-stop Transgene-Free Genome Editing in Plants to Support the Research of Plant Science

September 09 17:27 2021
CRISPR/Cas9 platform announced the release of its transgene-free genome editing in plants to accelerate the research in the field of plant science for basic research.

New York, USA – September 9, 2021 – CRISPR/Cas9 platform, the professional division of Creative Biogene, focuses on providing comprehensive gene-editing services and products by using CRISPR/Cas9 technology. With professional products and services, CRISPR/Cas9 platform is dedicated to supporting the progress of gene editing projects. Recently, CRISPR/Cas9 platform announced the release of its transgene-free genome editing in plants to accelerate the research in the field of plant science for basic research.

CRISPR/Cas9 platform provides one-stop plant genome editing services, including gene knockout, gene knock-in and gene deletion. The service provides a variety of species, including but not limited to Arabidopsis, corn, rice, and tobacco. The specific workflow includes the design and construction of SgRNA, the delivery of Cas9 and sgRNA to plant cells, as well as targeted mutation analysis and final delivery.

CRISPR/Cas9 platform focuses on genome editing technology and provides comprehensive services to establish genome editing plants with specific genome engineering modifications on target genes/locus of interest. It also helps customers generate commercially viable target gene-edited crops, and produce non-GMO, non-regulated and sustainable genome-edited plants.

CRISPR/Cas9 platform provides GMO-free genome editing services for rice, tomato and Arabidopsis. Non-transgenic edited plants are generally obtained through genetic separation through selfing and crossing of T0 plants. Subsequently, PCR-based genotyping was used to identify T1 plants without DNA. CRISPR/Cas9 Platform also provides other strategies, such as RNP/RNA-based methods and marker-assisted transgene elimination to meet specific requirements.

CRISPR/Cas9 platform has been committed to improving plant transformation efficiency and optimizing genome editing systems for many years. Two different base editors have recently been introduced, Cytosine Base Editor (CBE) and Adenine Base Editor (ABE). CBE realizes the efficient substitution of C·G to T·A, and ABE mediates the transformation of A·T to G·C in genomic DNA. CRISPR/Cas9 Platform combines a base editor with genetic transformation technology to generate single base substitutions in the plant genome. It has been applied to precision plant breeding and transformation in agriculture.

“With excellent experts and years of plant genome editing experience, we provide global customers with one-stop services from project design to genetically modified plant screening.” said Marcia Brady, the marketing director of Creative Biogene, she also added, “Also, we are committed to offering customized solutions to satisfy specific needs, providing professional consultation and evaluation for specific projects.”

About CRISPR/Cas9 platform

CRISPR/Cas9 platform, as a professional division of Creative Biogene, is dedicated to supporting our clients conduct genetic research with comprehensive gene-editing services and products as well as experienced in-house experts. With years of effort. Creative Biogene CRISPR/Cas9 platform has become a world-recognized industry platform that supports millions of scientists worldwide.

Media Contact
Company Name: Creative Biogene
Contact Person: Marcia Brady
Email: Send Email
Phone: 1-631-386-8241
Country: United States